Financial Year |
March 31 2023 |
Monetary Funds |
331,041,196.79 |
Held-for-trading Financial Assets |
20,006,000.00 |
Notes Receivable |
-- |
Accounts Receivable |
49,842,451.39 |
Advances to Suppliers |
41,108,152.40 |
Other Receivables |
16,341,741.66 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
322,961,201.47 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,013,904.62 |
Total Current Assets |
782,314,648.33 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
23,775,500.54 |
Investment Properties |
-- |
Fixed Assetes |
73,131,746.10 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
33,525,869.09 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
5,217,296.07 |
Deferred Income Tax Assets |
32,983,914.25 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
206,769,873.19 |
Total Assets |
989,084,521.52 |
Short-Term Loans |
70,141,847.59 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
47,285,808.77 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
18,584,868.82 |
Taxes Payable |
4,971,628.14 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
32,220,800.99 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,911,369.05 |
Other Current Liabilities |
802,702.95 |
Sub-Total of Current Liabilities |
184,096,115.68 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
864,659.06 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,639,422.95 |
Total Liabilities |
186,735,538.63 |
Paid-In Capital(Or Share Stock) |
221,360,000.00 |
Capital Surplus |
479,131,246.66 |
Surplus Reserve |
76,284,261.20 |
LESS:Treasury Stock |
6,817,400.00 |
Undistributed Profits |
29,383,784.43 |
Minority Stockholder's Interest |
3,007,090.60 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
799,341,892.29 |
Owner's Equity(Stockholder's Equity) |
802,348,982.89 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
989,084,521.52 |